Rathbones Group’s Vaxart VXRT Stock Holding History

Rathbones Group’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-41,000	Closed	-$234K	–	425
2020 Q4	$234K	Hold	41,000	–	–	﹤0.01%	353
2020 Q3	$273K	Hold	41,000	–	–	﹤0.01%	315
2020 Q2	$363K	Buy	+41,000	New	+$118K	0.01%	274

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Rathbones Group's VXRT Position: Q1 2021 in Review

Rathbones Group sold out of Vaxart (VXRT) in Q1 2021, closing a stake of 41,000 shares — an estimated $234K sold.

Rathbones Group first reported a position in VXRT in Q2 2020 and held it in 3 quarters. The position peaked at $363K in Q2 2020. 159 funds tracked by Wall St. Rank hold VXRT as of Q1 2021.

Rathbones Group reported no remaining Vaxart position as of Q1 2021 after selling out during the quarter.
Rathbones Group sold 41,000 Vaxart shares in Q1 2021, an estimated $234K.
Rathbones Group first reported a position in Vaxart in Q2 2020 and held it in 3 quarters.
Rathbones Group's Vaxart position peaked at $363K in Q2 2020.
159 funds tracked by Wall St. Rank held Vaxart as of Q1 2021.

Based on Rathbones Group's 13F filing for Q1 2021, filed 14 May 2021.